CD8A and central nervous system cancer: Researchers have studied the effects of miR-15a/16 on the antitumor immune response in glioma-infiltrating CD8+ T cells and observed that an miR-15a/16 deficiency in an orthotropic GL261 mouse glioma model attenuated cancer progression by inhibiting tumor growth and prolonged mouse survival.